The landscape of bispecific T cell engager in cancer treatment

• Váldodahkkit: Shujie Zhou (Dahkki), Mingguo Liu (Dahkki), Fei Ren (Dahkki), Xiangjiao Meng (Dahkki), Jinming Yu (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2021-05-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract T cell-based immunotherapies have revolutionized treatment paradigms in various cancers, however, limited response rates secondary to lack of significant T-cell infiltration in the tumor site remain a major problem. To address this limitation, strategies for redirecting T cells to treat can...